As per our research report “Global Vaccine Market Forecast to 2012”, a number of healthcare companies are focusing on cancer vaccine development process to enhance their profit. The cancer vaccine market is expected to grow at a CAGR of 25% during 2009-2012, on the back of government support and increasing participation of private players. We have identified various instances in our report that prove that now the focus has been shifted to cancer vaccines. Our report has also discussed other emerging trends in global vaccine market.
At country level analysis, we have found that the US grabbed the largest share in the vaccine market in 2009. Europe is the second largest vaccine market and a major vaccine manufacturer. Besides, the year 2009 witnessed some of the pharmaceutical companies setting up their bases in developing countries to cater their needs. The growing pharmaceutical market in these nations supported the global giants to set-up their base for vaccine production and research.
The global vaccine market has been broadly studied under various segments. On the basis of segment, adult vaccines enjoy the major market share and the future will see even more rapid growth in the adult vaccine segment, particularly in cancer and addiction segments. The report has deeply analyzed major vaccine segments. It has also studied the pediatric vaccines and therapeutics vaccines market.
Our study on mergers and acquisitions in the market shows that the vaccine market has attracted many pharma players from all around the world to invest in the market. We have also analyzed the investment risk involved in vaccine industry. The report has identified all the necessary factors and aspects related to market and represent current industry status with future forecast on vaccine types and countries for 2009-2012. In addition, the description of key players with key vaccine brands forecast to 2012 has been covered.
For more information visit: http://www.rncos.com/Report/IM153.htm |
.jpg "Global Vaccine Market Outlook (2007-2010)")
